Bactrim ds and Tecfidera drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bactrim ds (sulfamethoxazole; trimethoprim) and Tecfidera (dimethyl fumarate). Common drug interactions include generalised erythema among females and hyponatraemia among males.

The phase IV clinical study analyzes what interactions people have when they take Bactrim ds and Tecfidera. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Bactrim ds?

Bactrim ds has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 17,027 Bactrim ds users. Check the latest studies of Bactrim ds.

What is Tecfidera?

Tecfidera has active ingredients of dimethyl fumarate. It is often used in multiple sclerosis. eHealthMe is studying from 129,627 Tecfidera users. Check the latest studies of Tecfidera.



On Jul, 16, 2026

52 people who take Bactrim ds and Tecfidera together, and have interactions are studied.

Bactrim ds and Tecfidera drug interactions.

What are the common drug interactions of Bactrim Ds and Tecfidera, by gender? *:

female:

  1. Generalised erythema (redness of the skin all over the body)
  2. Hip fracture
  3. Immune thrombocytopenic purpura (destruction of blood platelets due to the presence of antiplatelet auto antibodies)
  4. Fall
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Decreased appetite
  7. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Heparin-induced thrombocytopenia
  10. Hot flush (sudden feelings of heat)

male:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Paraplegia (paralysis of the legs and lower body)
  3. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  4. Death
  5. Depressed mood
  6. Fatigue (feeling of tiredness)
  7. Hearing impaired
  8. Hyperhidrosis (abnormally increased sweating)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Tinnitus (a ringing in the ears)

What are the common drug interactions of Bactrim Ds and Tecfidera, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  3. Pneumonia
  4. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  5. Confusional state
  6. Constipation
  7. Decreased appetite
  8. Incontinence (lack of moderation or self-control)
  9. Tremor (trembling or shaking movements in one or more parts of your body)

40-49:

  1. Abdominal pain
  2. Biliary dilatation
  3. Dizziness
  4. Fatigue (feeling of tiredness)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Nausea (feeling of having an urge to vomit)
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Red blood cell count decreased
  9. White blood cell count decreased

50-59:

  1. Fatigue (feeling of tiredness)
  2. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  3. Blood urine present
  4. Depression
  5. Dysarthria (speech disorder)
  6. Dysgraphia (impaired ability to learn to write)
  7. Gait disturbance
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Micturition urgency (urgency to pass the urine)
  10. Muscular weakness (muscle weakness)

60+:

  1. Fall
  2. Decreased appetite
  3. Nocardiosis (an infectious disease affecting either the lungs or whole body)
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  6. Brain neoplasm (tumour of brain)
  7. Lung disorder (lung disease)
  8. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  9. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
  10. Cns ventriculitis (inflammation of the ventricles in the brain)

What are the existing conditions these people have? *

  1. Gait Disturbance: 6 people, 11.54%
  2. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 5.77%

* Approximation only. Some reports may have incomplete information.

Do you take Bactrim ds and Tecfidera?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bactrim ds and Tecfidera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bactrim ds:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tecfidera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bactrim ds and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tecfidera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim and dimethyl fumarate (the active ingredients of Bactrim ds and Tecfidera, respectively), and Bactrim ds and Tecfidera (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: